UC TUR.OP.END. BULL EAM/ DE000HC1RK28 /
| 06/08/2024 09:45:20 | Chg.-0.0100 | Bid10:23:14 | Ask10:23:14 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.8800EUR | -1.12% | 0.8900 Bid Size: 150,000 |
0.9000 Ask Size: 150,000 |
A2A | 0.989 EUR | 31/12/2078 | Call |
GlobeNewswire
10/05
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
06/05
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
19/03
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...
Newsfile Corp
08/03
Noda Presents Report on Key Payment Trends: Diverse PaymentMethods, AI, and More
GlobeNewswire
06/03
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
28/11/2023
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
GlobeNewswire
07/11/2023
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
07/11/2023
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire
06/11/2023
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
Newsfile Corp
04/10/2023
Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments
GlobeNewswire
21/09/2023
Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...
GlobeNewswire
20/09/2023
Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...
GlobeNewswire
05/09/2023
Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...
GlobeNewswire
30/08/2023
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update
GlobeNewswire
10/03/2022
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...
GlobeNewswire
03/03/2022
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
10/02/2022
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
GlobeNewswire
02/02/2022
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire
14/01/2022
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...
GlobeNewswire
09/12/2021
iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...
GlobeNewswire
12/11/2021
Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial ...
GlobeNewswire
10/11/2021
Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
